Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 5 Startups & Unicorns companies in Liquid biopsy
by Highest Patent Value in the United States in 2021

The Liquid biopsy top 5 is Discovery PatSnap’ annual ranking of the top 5 Highest Patent Value Liquid biopsy Startups & Unicorns in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2021, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
A liquid biopsy, also known as fluid biopsy or fluid phase biopsy, is the sampling and analysis of non-solid biological tissue, primarily blood. Like traditional biopsy this type of technique is mainly used as a diagnostic and monitoring tool for diseases such as cancer, with the added benefit of being largely non-invasive. Therefore, it can also be done more frequently which can better track tumors and mutations over a duration of time. It may also be used to validate the efficiency of a cancer treatment drug by taking multiple liquid biopsy samples in the span of a few weeks. The technology may also prove beneficial for patients after treatment to monitor relapse.
#
Company Name
Region
Tech Topics
Total
1
Genetic testing,Health technology,Health care
Avg patent value: 47,100
2
Machine learning,Health care,Clinical trial,
...[+2]
Avg patent value: 22,000
3
QCDx LLC
Avg patent value: 21,500
4
Avg patent value: 20,075
5
Salish Bioscience, Inc
Avg patent value: 20,000
Page generation time: May 11 2025